Ifosfamide--pharmacology, safety and therapeutic potential.
D000818:Animals; D001711:Biotransformation; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D012983:Soft Tissue Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy
D003520:Cyclophosphamide; D007069:Ifosfamide